Scott Haake, MD, PhD, is an Assistant Professor of Medicine in the Division of Hematology Oncology within the Department of Medicine at Vanderbilt University Medical Center.
Dr. Haake is a kidney cancer investigator and leads a research team focused on tumor cell interaction with the extracellular matrix, integrin signaling, biomarker development, and kidney cancer biology. His work spans multiple projects, including basic cancer biology research, animal models of cancer, translational work in human tissues and clinical trials.
Dr. Haake has been funded by the National Cancer Institute, the Kidney Cancer Association, the American Urological Association, the American Society of Clinical Oncology, the American Association of Cancer Research, the Kure It Foundation, and the Department of Defense Kidney Cancer Research Program. As a board-certified medical oncologist, he has a kidney and genitourinary cancer-focused clinic and cares for patients at both Vanderbilt University Medical Center and the Nashville VA Hospital.
Dr. Haake received Young Investigator Awards by the American Association of Cancer Research (2015) and the Kidney Cancer Association (2019). He has also received a Research Scholars Award from the American Urological Association (2016). In 2008 Dr. Haake was elected to the Alpha Omega Alpha national medical honor society. In 2005, he received the King-O’Neal Scholar Award, an award reserved for those graduating first in their class at the University of South Florida.